Don’t Forget About the Liver! NASH in Patients With HIV

Download All
Learn about the prevalence, assessment, and current and future treatment landscape for nonalcoholic steatohepatitis in patients with HIV.
Jürgen K. Rockstroh, MD
Giada Sebastiani, MD
Mark S. Sulkowski, MD

ClinicalThought

The presence of obesity, metabolic syndrome, persistent elevation of ALT, or exposure to dideoxynucleoside analogues can trigger an evaluation for NAFLD and NASH, particularly in our aging population of patients with HIV.

Giada Sebastiani, MD Released: September 29, 2021

Here are my best practices to appropriately screen for and identify NASH among people with HIV.

Jürgen K. Rockstroh, MD Released: January 7, 2022

Here’s my take on why abnormal ALT is never “normal” and why patients with HIV and abnormal liver enzymes need our attention.

Mark S. Sulkowski, MD Released: January 10, 2022

Medical Minutes

What puts your patients with HIV at risk for steatohepatitis or NASH? Review the increasing prevalence of fatty liver disease, the spectrum of disease from NAFLD to NASH, and the overlap in the epidemics of NASH and HIV.

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: December 7, 2021 Expired: December 6, 2022

Review the pathogenesis of NASH in patients with HIV, including the role of metabolic comorbidities, long-term ART, and risk factors that contribute to NASH development especially among the aging population.

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: January 6, 2022 Expired: January 5, 2023

Learn best practices for screening strategies and diagnosing NASH in patients with HIV.

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: January 10, 2022 Expired: January 9, 2023

Learn how and why lifestyle modification, weight reduction, and pharmacotherapy may benefit patients with HIV and NASH.

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: January 10, 2022 Expired: January 9, 2023

Podcasts

In this podcast episode, listen to hepatologist Giada Sebastiani, MD, discuss why the presence of obesity, metabolic syndrome, persistent elevation of ALT, or exposure to dideoxynucleoside analogues should trigger an evaluation for NAFLD and NASH, particularly in our aging population of patients with HIV.

Giada Sebastiani, MD Released: November 10, 2021

In this podcast episode, listen to Jürgen K. Rockstroh, MD, discuss his recommended approach for diagnosing NASH in patients with HIV, the value of noninvasive diagnostic tests such as serum biomarkers and elastography, and how timely NAFLD assessment and metabolic risk factor determination can result in early interventions.

Jürgen K. Rockstroh, MD Released: February 3, 2022

In this podcast episode, listen to Mark S. Sulkowski, MD, discuss his recommended approach for managing NASH in patients with HIV, including recognizing NASH, recommending lifestyle interventions, and considering pharmacologic approaches.

Mark S. Sulkowski, MD Released: February 15, 2022

In this podcast episode, listen to experts Jürgen K. Rockstroh, MD, and Giada Sebastiani, MD, interact directly with healthcare professionals and give authoritative answers to pressing questions about NASH in the setting of HIV.

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Released: February 9, 2022

Downloadable Slideset

Comprehensive slideset featuring key data on the prevalence, assessment, and treatment landscape for nonalcoholic steatohepatitis (NASH) in people living with HIV.

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Released: February 9, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Theratechnologies Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings